T1-weighted dynamic contrast-enhanced MR perfusion imaging characterizes tumor response to radiation therapy in chordoma Journal Article
| Authors: | Santos, P.; Peck, K. K.; Arevalo-Perez, J.; Karimi, S.; Lis, E.; Yamada, Y.; Holodny, A. I.; Lyo, J. |
| Article Title: | T1-weighted dynamic contrast-enhanced MR perfusion imaging characterizes tumor response to radiation therapy in chordoma |
| Abstract: | BACKGROUND AND PURPOSE: Chordomas notoriously demonstrate a paucity of changes following radiation therapy on conventional MR imaging. We hypothesized that dynamic contrast-enhanced MR perfusion imaging parameters of chordomas would change significantly following radiation therapy. MATERIALS AND METHODS: Eleven patients with pathology-proved chordoma who completed dynamic contrast-enhanced MR perfusion imaging pre- and postradiation therapy were enrolled. Quantitative tumor measurements were obtained by 2 attending neuroradiologists. ROIs were used to calculate vascular permeability and plasma volume and generate dynamic contrast-enhancement curves. Quantitative analysis was performed to determine mean and maximum plasma volume and vascular permeability values, while semiquantitative analysis on averaged concentration curves was used to determine the area under the curve. A Mann-Whitney U test at a significance level of P < .05 was used to assess differences of the above parameters between pre- and postradiation therapy. RESULTS: Plasma volume mean (pretreatment mean = 0.82; posttreatment mean = 0.42), plasma volume maximum (pretreatment mean=3.56; posttreatment mean=2.27), and vascular permeability mean (pretreatment mean=0.046; posttreatment mean=0.028) in the ROIs significantly decreased after radiation therapy (P < .05); this change thereby demonstrated the potential for assessing tumor response. Area under the curve values also demonstrated significant differences (P < .05). CONCLUSIONS: Plasma volume and vascular permeability decreased after radiation therapy, suggesting that these dynamic contrastenhanced MR perfusion parameters may be useful for monitoring chordoma growth and response to radiation therapy. Additionally, the characteristic dynamic MR signal intensity-time curve of chordoma may provide a radiographic means of distinguishing chordoma from other spinal lesions. |
| Keywords: | clinical article; treatment response; cancer radiotherapy; nuclear magnetic resonance imaging; outcome assessment; retrospective study; quantitative analysis; contrast enhancement; gadolinium pentetate; chordoma; blood vessel permeability; plasma volume; human; article; neuroradiologist |
| Journal Title: | American Journal of Neuroradiology |
| Volume: | 38 |
| Issue: | 11 |
| ISSN: | 0195-6108 |
| Publisher: | American Society of Neuroradiology |
| Date Published: | 2017-11-01 |
| Start Page: | 2210 |
| End Page: | 2216 |
| Language: | English |
| DOI: | 10.3174/ajnr.A5383 |
| PROVIDER: | scopus |
| PUBMED: | 28912284 |
| PMCID: | PMC5759964 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 2 January 2018 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work